Recommendations on the Management of EoE (cont'd)
Statement
Strength of
recommendation
Quality of
evidence
8. Recommendation: In adult patients with dysphagia
from a stricture associated with EoE, the AGA/JTF
suggests endoscopic dilation over no dilation.
Comment: Esophageal dilation does not address the
esophageal inflammation associated with EoE.
Conditional Very low
9. In patients with EoE, the AGA/JTF recommends
using anti-IL-5 therapy for EoE only in the context
of a clinical trial.
No
recommendation
Knowledge
gap
10. In patients with EoE, the AGA/JTF recommends
using anti-IL-13 or anti-IL-4 receptor a therapy for
EoE only in the context of a clinical trial.
No
recommendation
Knowledge
gap
11. In patients with EoE, the AGA/JTF suggests
against the use of anti-IgE therapy for EoE.
Conditional Very low
12-15. In patients with EoE the AGA/JTF suggest
using montelukast, cromolyn sodium,
immunomodulators, and anti-TNF for EoE
only in the context of a clinical trial.
No
recommendation
Knowledge
gap
Management
